Abstract
Transcription-dependent apoptosis triggered by p53 hardly occurs in alternative reading frame (ARF)-null cancer cells. Loss of ARF leads to hyperactivation of murine double minute 2 (MDM2), resulting in the degradation of p53. In the present study, A549 (ARF-null) human non-small lung cancer cells were transfected with a plasmid DNA encoding human wild-type p53 and the mitochondrial transmembrane domain of Tom5 (p53-Tom5) for delivering p53 to mitochondria. As a result, p53-Tom5 exclusively localized at mitochondria in A549 cells and suppressed the proliferation of them, whereas wild-type p53 did not. In addition, mitochondrial dysfunction and release of cytochrome c were induced by p53-Tom5 in A549 cells. These data suggest that p53-Tom5 suppressed the proliferation of A549 cells through direct mitochondrial dysfunction. © 2011 Pharmaceutical Society of Japan.
Author supplied keywords
Cite
CITATION STYLE
Umemoto, T., Asai, T., Hirashima, K., Shimizu, K., Mihara, M., Yamamoto, K., … Oku, N. (2011). Proapoptotic action of p53-Tom5 in p53-resistant A549 human nonsmall cell lung cancer cells through direct mitochondrial dysfunction. Biological and Pharmaceutical Bulletin, 34(4), 551–554. https://doi.org/10.1248/bpb.34.551
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.